| Immune dysregulation in cancer patients developing immune-related adverse events S Khan, SA Khan, X Luo, FJ Fattah, J Saltarski, Y Gloria-McCutchen, R Lu, ... British journal of cancer 120 (1), 63-68, 2019 | 152 | 2019 |
| An empirical approach leveraging tumorgrafts to dissect the tumor microenvironment in renal cell carcinoma identifies missing link to prognostic inflammatory factors T Wang, R Lu, P Kapur, BS Jaiswal, R Hannan, Z Zhang, I Pedrosa, ... Cancer discovery 8 (9), 1142-1155, 2018 | 149 | 2018 |
| Variation in the assessment of immune-related adverse event occurrence, grade, and timing in patients receiving immune checkpoint inhibitors D Hsiehchen, MK Watters, R Lu, Y Xie, DE Gerber JAMA network open 2 (9), e1911519-e1911519, 2019 | 63 | 2019 |
| Artificial intelligence enables whole-body positron emission tomography scans with minimal radiation exposure YR Wang, L Baratto, KE Hawk, AJ Theruvath, A Pribnow, AS Thakor, ... European journal of nuclear medicine and molecular imaging 48, 2771-2781, 2021 | 53 | 2021 |
| Identifying Factors Associated with Head Impact Kinematics and Brain Strain in High School American Football via Instrumented Mouthguards NJ Cecchi, AG Domel, Y Liu, E Rice, R Lu, X Zhan, Z Zhou, SJ Raymond, ... Annals of biomedical engineering 49, 2814-2826, 2021 | 38 | 2021 |
| Ligand-free estrogen receptor α (ESR1) as master regulator for the expression of CYP3A4 and other cytochrome P450 enzymes in the human liver D Wang, R Lu, G Rempala, W Sadee Molecular pharmacology 96 (4), 430-440, 2019 | 27 | 2019 |
| Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors MS von Itzstein, AS Gonugunta, Y Wang, T Sheffield, R Lu, S Ali, FJ Fattah, ... Cancer Immunology, Immunotherapy 71 (9), 2169-2181, 2022 | 21 | 2022 |
| Estimation of Sobol's sensitivity indices under generalized linear models R Lu, D Wang, M Wang, GA Rempala Communications in Statistics-Theory and Methods 47 (21), 5163-5195, 2018 | 21 | 2018 |
| Late‐Onset Immunotherapy Toxicity and Delayed Autoantibody Changes: Checkpoint Inhibitor–Induced Raynaud's‐Like Phenomenon S Khan, MS von Itzstein, R Lu, BL Bermas, DR Karp, SA Khan, FJ Fattah, ... The Oncologist 25 (5), e753-e757, 2020 | 19 | 2020 |
| Incidence of interstitial lung disease in patients with rheumatoid arthritis treated with biologic and targeted synthetic disease-modifying antirheumatic drugs MC Baker, Y Liu, R Lu, J Lin, J Melehani, WH Robinson JAMA Network Open 6 (3), e233640-e233640, 2023 | 17 | 2023 |
| Mobile device applications for electronic patient portals in oncology KK Pho, R Lu, S Gates, J Cai, D Xie, Y Xie, SJC Lee, DE Gerber JCO clinical cancer informatics 3, 1-8, 2019 | 17 | 2019 |
| Characteristics of patients using patient portals in oncology K Pho, R Lu, S Gates, Y Xie, SJC Lee, DE Gerber JAMA oncology 4 (3), 416-418, 2018 | 16 | 2018 |
| Diagnostic Accuracy of 2-[18F]FDG-PET and whole-body DW-MRI for the detection of bone marrow metastases in children and young adults A Rashidi, L Baratto, AJ Theruvath, EB Greene, KE Hawk, R Lu, MP Link, ... European radiology 32 (7), 4967-4979, 2022 | 14 | 2022 |
| Measurable residual disease status and FLT3 inhibitor therapy in patients with FLT3-ITD mutated AML following allogeneic hematopoietic cell transplantation EC Liang, C Chen, R Lu, GN Mannis, L Muffly Blood 138, 1306, 2021 | 14 | 2021 |
| Development and validation of a nomogram prognostic model for patients with advanced non-small-cell lung cancer T Wang, R Lu, S Lai, JH Schiller, FL Zhou, B Ci, S Wang, X Gao, B Yao, ... Cancer Informatics 18, 1176935119837547, 2019 | 13 | 2019 |
| Closing the gap: Contribution of surgical best practices to outcome differences between high‐and low‐volume centers for lung cancer resection MS von Itzstein, R Lu, KH Kernstine, EA Halm, S Wang, Y Xie, DE Gerber Cancer Medicine 9 (12), 4137-4147, 2020 | 12 | 2020 |
| Analyzing allele specific RNA expression using mixture models R Lu, RM Smith, M Seweryn, D Wang, K Hartmann, A Webb, W Sadee, ... BMC genomics 16, 1-11, 2015 | 12 | 2015 |
| Statin Intolerance, Anti‐HMGCR Antibodies, and Immune Checkpoint Inhibitor‐Associated Myositis: A “Two‐Hit” Autoimmune Toxicity or Clinical Predisposition? MS von Itzstein, S Khan, V Popat, R Lu, SA Khan, FJ Fattah, JY Park, ... The oncologist 25 (8), e1242-e1245, 2020 | 11 | 2020 |
| Lack of association between radiographic tumor burden and efficacy of immune checkpoint inhibitors in advanced lung cancer V Popat, R Lu, M Ahmed, JY Park, Y Xie, DE Gerber The oncologist 25 (6), 515-522, 2020 | 10 | 2020 |
| Impact of presence of children on indoor tobacco restrictions in households of urban and rural adult tobacco users BT Kopp, A Hinton, R Lu, S Cooper, H Nagaraja, ME Wewers Academic pediatrics 18 (8), 920-927, 2018 | 8 | 2018 |
